Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied
In Brief: Wyngaarden Delays Gene Transfer Study, Seeks all Information; Rosenberg Wins Griffuel Prize
Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)
DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated